Multimediator dopamine transport inhibitors, and uses...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/454 (2006.01) A61P 25/24 (2006.01) C07D 401/12 (2006.01)

Patent

CA 2614731

The invention provides a class of DAT--5HT2 antagonists, packaged pharmaceuticals comprising such antagonists, and their uses in treating, or the manufacturing medicaments for treating disease conditions, inlcuding a movement disorder, attention deficit disorder or attention-deficit hyperactivity disorder, anxiety, depression or psychotic disorder. Related business methods such as marketing the inhibitors to healthcare providers are also provided.

L'invention concerne une classe d'antagonistes DAT--5HT2, des produits pharmaceutiques conditionnés comprenant ces antagonistes et leurs utilisations dans le traitement ou la fabrication de médicaments permettant de traiter des états pathologiques, telles qu'un trouble moteur, le trouble déficitaire de l'attention ou le trouble d'hyperactivité avec déficit de l'attention, l'anxiété, la dépression ou un trouble psychotique. L'invention concerne également des procédés commerciaux associés, tels que la commercialisation de ces inhibiteurs auprès des fournisseurs de soins de santé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Multimediator dopamine transport inhibitors, and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multimediator dopamine transport inhibitors, and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multimediator dopamine transport inhibitors, and uses... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1903841

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.